About the Anticancer Drug Formulation Session
In the realm of cancer research, the formulation of anticancer drugs represents a cornerstone in the fight against this formidable disease. Scientists continually innovate to develop drug formulations that target cancer cells while minimizing damage to healthy tissues. Nanotechnology has emerged as a promising avenue, enabling the precise delivery of therapeutic agents directly to tumors, thereby enhancing efficacy and reducing side effects. Furthermore, advancements in personalized medicine have led to tailored drug formulations based on an individual's genetic makeup and the specific characteristics of their cancer. By harnessing cutting-edge technologies and interdisciplinary approaches, researchers strive to develop increasingly sophisticated anticancer drug formulations that offer improved outcomes and better quality of life for patients battling cancer.
Topics Covered in Anticancer Drug Formulation
Nanoparticle Delivery
Liposomal Formulations
Polymeric Micelles
Oral Bioavailability
Controlled-Release Systems
Solubility Enhancement
Related Scientific Sessions at CIOC 2027
Why Attend the Anticancer Drug Formulation Conference 2027
Earn CPD Credit
Sessions are CPD-accredited; certificates issued to every registered delegate within two weeks of the conference.
Present Your Research
Oral and poster slots for original Anticancer Drug Formulation work, reviewed by the scientific committee.
Network Globally
Meet oncologists, cancer researchers, and clinical specialists from around the world across three days.
Publish & Get Indexed
Accepted abstracts appear in the indexed conference proceedings with a citable DOI.
Learn from Keynotes
Plenary lectures from leading voices shaping Anticancer Drug Formulation research and practice.
Hybrid Flexibility
Attend in person in Singapore or join virtually — same programme, same certificate.
Join CIOC 2027 for the Anticancer Drug Formulation track
Oral and poster slots for your work — in person in Singapore or online. Not presenting? Attend as a delegate to learn from the field.
Anticancer Drug Formulation Conference 2027 — FAQs
What is the Anticancer Drug Formulation track at CIOC 2027?
The Anticancer Drug Formulation track is a dedicated stream within CIOC 2027 covering the latest research, clinical innovation, and best practice in Anticancer Drug Formulation. It brings together researchers, educators, and practitioners for oral presentations, posters, and discussion.
Who should attend the Anticancer Drug Formulation sessions?
Cancer researchers and clinicians, educators and students with an interest in Anticancer Drug Formulation are all welcome — whether presenting or attending.
Can I present my research in the Anticancer Drug Formulation track?
Yes. Submit an abstract for oral or poster presentation. All submissions are peer-reviewed by the scientific committee; accepted abstracts appear in the indexed proceedings.
Is virtual attendance available for Anticancer Drug Formulation sessions?
Yes. CIOC 2027 is a hybrid conference — attend the Anticancer Drug Formulation track in person in Singapore or join live online, with on-demand access afterward.
Join the CIOC 2027 delegation
Singapore · March 15–17, 2027· Hybrid · in-person & virtual
Attend without presenting.